SI
PFE icon

Sofinnova Investments’s Pfizer PFE Stock Holding History

Sofinnova Investments’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.5M Buy
+800,000
New +$21.3M 0.85% 36
2020
Q3 		– Sell
-184,450
Closed -$5.72M – 82
2020
Q2 		$5.72M Buy
+184,450
New +$6.27M 0.36% 52

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Sofinnova Investments's PFE Position: Q2 2022 in Review

Sofinnova Investments sold out of Pfizer (PFE) in Q2 2022, closing a stake of 49,378 shares — an estimated $2.56M sold.

Sofinnova Investments first reported a position in PFE in Q3 2019 and held it in 2 quarters. The position peaked at $14.8M in Q3 2019. 3,157 funds tracked by Wall St. Rank hold PFE as of Q2 2022.

  • Sofinnova Investments reported no remaining Pfizer position as of Q2 2022 after selling out during the quarter.
  • Sofinnova Investments sold 49,378 Pfizer shares in Q2 2022, an estimated $2.56M.
  • Sofinnova Investments first reported a position in Pfizer in Q3 2019 and held it in 2 quarters.
  • Sofinnova Investments's Pfizer position peaked at $14.8M in Q3 2019.
  • 3,157 funds tracked by Wall St. Rank held Pfizer as of Q2 2022.

Based on Sofinnova Investments's 13F filing for Q2 2022, filed 15 Aug 2022.